FAKTORY ROSTA FIBROBLASTOV 1 I 2 TIPA V SYVOROTKE KROVI PRI ZLOKAChESTVENNYKh OPUKhOLYaKh KOSTEY
A A Alferov , E A Ten , S S Babkin , A I Batyrev
Medical academic journal ›› 2016, Vol. 16 ›› Issue (4) : 96 -97.
FAKTORY ROSTA FIBROBLASTOV 1 I 2 TIPA V SYVOROTKE KROVI PRI ZLOKAChESTVENNYKh OPUKhOLYaKh KOSTEY
| [1] |
Tsuji K., Noda M. Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells // J. Bone Miner. Metab.- 2001.- Vol. 19, № 4.- P. 213-219 |
| [2] |
Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation / Bodo M., Lilli C., Bellucci C., Carinci P., Calvitti M., Pezzetti F., Stabellini G., Bellocchio S., Balducci C., Carinci F., Baroni T. // Mol. Med.- 2002.- Vol. 8, № 7.- P. 393-404. |
| [3] |
Powers C. J., McLeskey S. W., Wellstein A. Fibroblast growth factors, their receptors and signaling / / Endocr. Relat. Cancer.- 2000.- Vol. 7, № 3.- P. 165-197. |
| [4] |
The correlation between the level of serum VEGF and bFGF with metastasis and prognosis of osteosarcoma / Chen G. L., Lin H. B., Wu X. W., Li R. Y., Chen X. H. // Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.- 2011.- Vol. 27, № 12.- P. 1343-1345. |
| [5] |
Clinical predictive value of serum angiogenic factor in patients with osteosarcoma / Chen Z., Chen Q. X., Hou Z. Y., Hu J., Cao Y. G. // Asian Pac. J. Cancer. Prev.- 2012.- Vol. 13, № 9.- P. 4823-4826. |
Alferov A.A., Ten E.A., Babkin S.S., Batyrev A.I.
/
| 〈 |
|
〉 |
PDF
